Eiko Lifesciences Ltd — Important, 01-11-2025: Company Update

Eiko LifeSciences has published its financial results for the quarter and half-year ended September 30, 2025, which were approved by its Board of Directors. For the quarter, standalone total income from operations was ₹9.76 Cr, with a net profit after tax of ₹0.82 Cr and Basic EPS of ₹0.60. Consolidated total income reached ₹11.93 Cr, with a net profit after tax of ₹1.71 Cr and Basic EPS of ₹0.78. These results offer key insights into the company’s recent performance and are available on the company and stock exchange websites.